The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis
Open accessAbstract
Innate and adaptive immunity represent a harmonic counterbalanced system involved in the induction, progression, and possibly resolution of the inflammatory reaction that characterize autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis (RA). Although the immunopathophysiological mechanisms of the ARDs are not fully clarified, they are often associated with an inappropriate macrophage/T-cell interaction, where classical (M1) or alternative (M2) macrophage activation may influence the occurrence of T-helper (Th)1 or Th2 responses. In RA patients, M1/Th1 activation occurs in an inflammatory environment dominated by Toll-like receptor (TLR) and interferon (IFN) signaling, and it promotes a massive production of pro-inflammatory cytokines [i.e., tumor necrosis factor-α (TNFα), interleukin (IL)-1, IL-12, IL-18, and IFNγ], chemotactic factors, and matrix metalloproteinases resulting in osteoclastogenesis, erosion, and progressive joint destruction. On the other hand, the activation of M2/Th2 response determines the release of growth factors and cytokines [i.e., IL-4, IL-10, IL-13, and transforming growth factor (TGF)-β] involved in the anti-inflammatory process leading to the clinical remission of RA. Several subtypes of macrophages have been described. Five polarization states from M1 to M2 have been confirmed in in vitro studies analyzing morphological characteristics, gene expression of phenotype markers (CD80, CD86, TLR2, TLR4, or CD206, CD204, CD163, MerTK), and functional aspect, including the production of reactive oxygen species (ROS). An M1 and M2 macrophage imbalance may induce pathological consequences and contribute to several diseases, such as asthma or osteoclastogenesis in RA patients. In addition, the macrophage dynamic polarization from M1 to M2 includes the presence of intermediate polarity stages distinguished by the expression of specific surface markers and the production/release of distinct molecules (i.e., nitric oxide, cytokines), which characterize their morphological and functional state. This suggests a “continuum” of macrophage activation states playing an important role during inflammation and its resolution. This review discusses the importance of the delicate M1/M2 imbalance in the different phases of the inflammatory process together with the identification of specific pathways, cytokines, and chemokines involved, and its clinical outcomes in RA. The analysis of these aspects could shed a light on the abnormal inflammatory activation, leading to novel therapeutical approaches which may contribute to restore the M1/M2 balance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“Indeed, plasticity is a key feature also of macrophages, which are capable of presenting heterogeneous phenotypes creating various subpopulations; therefore, these cells are not only involved in the propagation of inflammation but also in its resolution, depending on their activation state (M1 or M2) (37).”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514 · cited 1×
“Although RA pathophysiology remains elusive, the presence of a complex interplay among genotype, epigenetic changes, and environmental factors underlying chronic inflammation is abundantly described (7, 8).”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 1×
“org 4 maturation; this is a fundamental function in the regulation of inflammation and in the maintenance of homeostasis (35, 36).”
BackgroundSuccinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
Nomenclature of monocytes and dendritic cells in blood
Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J. M., Liu, Y.-J., MacPherson, G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Lee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,247
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Kapellos, T. S., Bonaguro, L., Gemünd, I., Reusch, N., Saglam, A., Hinkley, E. R., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02035 · Cited by 890
Nell, V. P. K. (2004) · Rheumatology · doi:10.1093/rheumatology/keh199 · Cited by 818
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807 · cited 1×
“Several studies revealed how the high expression levels of de novo DNA methyltransferase 3A (DNMT3A) and the methylcytosine dioxygenase ten–eleven traslocation-2 (TET2) in monocytes are essential for the differentiation and activation of these cells during inflammatory responses, suggesting how DNA methylation represe…”
BackgroundRheumatoid Arthritis: A Brief Overview of the Treatment
Bullock, J., Rizvi, S. A. A., Saleh, A. M., Ahmed, S. S., Do, D. P., Ansari, R. A., & Ahmed, J. (2018) · Medical Principles and Practice · doi:10.1159/000493390 · Cited by 776
Alivernini, S., MacDonald, L., Elmesmari, A., Finlay, S., Tolusso, B., Gigante, M. R., Petricca, L., Di Mario, C., Bui, L., Perniola, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0939-8 · Cited by 740 · cited 7×
“Conversely, active RA patients were characterized by the presence of MerTKCD206macrophages in the lining layer of the synovial tissue (64).”
BackgroundInfluentialMacrophage heterogeneity in the context of rheumatoid arthritis
Udalova, I. A., Mantovani, A., & Feldmann, M. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.91 · Cited by 686
Zizzo, G., Hilliard, B. A., Monestier, M., & Cohen, P. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200662 · Cited by 646
Cohen, P. L., Caricchio, R., Abraham, V., Camenisch, T. D., Jennette, J. C., Roubey, R. A. S., Earp, H. S., Matsushima, G., & Reap, E. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012094 · Cited by 636
Locally renewing resident synovial macrophages provide a protective barrier for the joint
Culemann, S., Grüneboom, A., Nicolás-Ávila, J. Á., Weidner, D., Lämmle, K. F., Rothe, T., Quintana, J. A., Kirchner, P., Krljanac, B., Eberhardt, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1471-1 · Cited by 625
The microbiome and rheumatoid arthritis
Scher, J. U., & Abramson, S. B. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.121 · Cited by 474
Myers, K. V., Amend, S. R., & Pienta, K. J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1022-2 · Cited by 470
Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029751 · Cited by 457
Macrophages: The Good, the Bad, and the Gluttony
Ross, E. A., Devitt, A., & Johnson, J. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708186 · Cited by 431
Macrophage polarization and allergic asthma
Saradna, A., Do, D. C., Kumar, S., Fu, Q.-L., & Gao, P. (2018) · Translational Research · doi:10.1016/j.trsl.2017.09.002 · Cited by 424
Takeda, K., & Akira, S. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s109 · Cited by 421
The gut–joint axis in rheumatoid arthritis
Zaiss, M. M., Joyce Wu, H.-J., Mauro, D., Schett, G., & Ciccia, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00585-3 · Cited by 389
Ramprasad, M. P., Terpstra, V., Kondratenko, N., Quehenberger, O., & Steinberg, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14833 · Cited by 387
Takeda, K., & Akira, S. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s77 · Cited by 378
Nonclassical Patrolling Monocyte Function in the Vasculature
Thomas, G., Tacke, R., Hedrick, C. C., & Hanna, R. N. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304650 · Cited by 367
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Navegantes, K. C., de Souza Gomes, R., Pereira, P. A. T., Czaikoski, P. G., Azevedo, C. H. M., & Monteiro, M. C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1141-8 · Cited by 358
Madsen, D. H., Leonard, D., Masedunskas, A., Moyer, A., Jürgensen, H. J., Peters, D. E., Amornphimoltham, P., Selvaraj, A., Yamada, S. S., Brenner, D. A., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201301081 · Cited by 351
Rossol, M., Kraus, S., Pierer, M., Baerwald, C., & Wagner, U. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33418 · Cited by 345
van Hamburg, J. P., Asmawidjaja, P. S., Davelaar, N., Mus, A. M. C., Colin, E. M., Hazes, J. M. W., Dolhain, R. J. E. M., & Lubberts, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30093 · Cited by 341
CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis
Kawanaka, N., Yamamura, M., Aita, T., Morita, Y., Okamoto, A., Kawashima, M., Iwahashi, M., Ueno, A., Ohmoto, Y., & Makino, H. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10545 · Cited by 322
Muraille, E., Leo, O., & Moser, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00603 · Cited by 311
Rana, A. K., Li, Y., Dang, Q., & Yang, F. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.016 · Cited by 303
Cells of the synovium in rheumatoid arthritis. Macrophages
Kinne, R. W., Stuhlmüller, B., & Burmester, G.-R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2333 · Cited by 300
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Rubbert-Roth, A., Enejosa, J., Pangan, A. L., Haraoui, B., Rischmueller, M., Khan, N., Zhang, Y., Martin, N., & Xavier, R. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008250 · Cited by 298
Alternatively activated macrophages; a double-edged sword in allergic asthma
Abdelaziz, M. H., Abdelwahab, S. F., Wan, J., Cai, W., Huixuan, W., Jianjun, C., Kumar, K. D., Vasudevan, A., Sadek, A., Su, Z., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02251-w · Cited by 287
A role for Mer tyrosine kinase in αvβ5 integrin-mediated phagocytosis of apoptotic cells
Wu, Y., Singh, S., Georgescu, M.-M., & Birge, R. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.01632 · Cited by 278
A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily
Law, S. K. A., Micklem, K. J., Shaw, J. M., Zhang, X., Dong, Y., Willis, A. C., & Mason, D. Y. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230940 · Cited by 275
Iwahashi, M., Yamamura, M., Aita, T., Okamoto, A., Ueno, A., Ogawa, N., Akashi, S., Miyake, K., Godowski, P. J., & Makino, H. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20219 · Cited by 267
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis
Klareskog, L., Malmström, V., Lundberg, K., Padyukov, L., & Alfredsson, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.014 · Cited by 244
A broken Krebs cycle in macrophages
O’Neill, L. A. J. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.017 · Cited by 232
Elie Metchnikoff: Father of natural immunity
Gordon, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838855 · Cited by 232
Firestein, G. S., & Zvaifler, N. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.502 · Cited by 214
Fukui, S., Iwamoto, N., Takatani, A., Igawa, T., Shimizu, T., Umeda, M., Nishino, A., Horai, Y., Hirai, Y., Koga, T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01958 · Cited by 209
Abatacept: A Review in Rheumatoid Arthritis
Blair, H. A., & Deeks, E. D. (2017) · Drugs · doi:10.1007/s40265-017-0775-4 · Cited by 199
Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1
Hasegawa, T., Kikuta, J., Sudo, T., Matsuura, Y., Matsui, T., Simmons, S., Ebina, K., Hirao, M., Okuzaki, D., Yoshida, Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0526-7 · Cited by 188
A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology
Rose, B. J., & Kooyman, D. L. (2016) · Disease Markers · doi:10.1155/2016/4895050 · Cited by 181
Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
Degboé, Y., Rauwel, B., Baron, M., Boyer, J.-F., Ruyssen-Witrand, A., Constantin, A., & Davignon, J.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00003 · Cited by 174 · cited 3×
“The mechanism that promotes this polarization involves the activation of Gas6 and SOCS3 and the subsequent increase in IL10, a process mediated by the induction of STAT3 signaling pathway (Table 1) (101).”
BackgroundInfluentialYang, X., Chang, Y., & Wei, W. (2020) · Cell Proliferation · doi:10.1111/cpr.12854 · Cited by 174
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts
Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K., & Miyasaka, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2046 · Cited by 170
Managing Macrophages in Rheumatoid Arthritis by Reform or Removal
Li, J., Hsu, H., & Mountz, J. D. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0272-4 · Cited by 168
Kelley and Firestein's Textbook of Rheumatology
(2017) · Elsevier eBooks · doi:10.1016/c2013-1-19259-3 · Cited by 168
Novel insights into macrophage diversity in rheumatoid arthritis synovium
Boutet, M.-A., Courties, G., Nerviani, A., Le Goff, B., Apparailly, F., Pitzalis, C., & Blanchard, F. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102758 · Cited by 165
Ambarus, C. A., Noordenbos, T., de Hair, M. J., Tak, P. P., & Baeten, D. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3796 · Cited by 158
Synovial tissue macrophages: friend or foe?
Kurowska‐Stolarska, M., & Alivernini, S. (2017) · RMD Open · doi:10.1136/rmdopen-2017-000527 · Cited by 153
The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction.
Burger, D., & Dayer, J. (2002) · Arthritis Research · doi:10.1186/ar558 · Cited by 142
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Elemam, N. M., Hannawi, S., & Maghazachi, A. A. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s243636 · Cited by 139
Rodríguez‐Ubreva, J., Català‐Moll, F., Obermajer, N., Álvarez‐Errico, D., Ramírez, R. N., Vento‐Tormo, R., Moreno‐Bueno, G., Edwards, R. P., Mortazavi, A., Kaliński, P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.018 · Cited by 134
Zhao, Q., Chu, Z., Zhu, L., Yang, T., Wang, P., Liu, F., Huang, Y., Zhang, F., Zhang, X., Ding, W., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00637 · Cited by 133
Viatte, S., Plant, D., Bowes, J., Lunt, M., Eyre, S., Barton, A. C., & Worthington, J. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201225 · Cited by 124
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms
Cutolo, M., Villaggio, B., Otsa, K., Aakre, O., Sulli, A., & SERIOLO, B. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.019 · Cited by 118
Self-citationInflammatory Osteoclasts Prime TNFα-Producing CD4+ T Cells and Express CX3CR1
Ibáñez, L., Abou-Ezzi, G., Ciucci, T., Amiot, V., Belaïd, N., Obino, D., Mansour, A., Rouleau, M., Wakkach, A., & Blin-Wakkach, C. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2868 · Cited by 117
Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts
Donlin, L. T., Jayatilleke, A., Γιαννοπούλου, Ε., Kalliolias, G. D., & Ivashkiv, L. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400486 · Cited by 117
Yoon, B. R., Yoo, S.-J., Choi, Y. H., Chung, Y., Kim, J., Yoo, I. S., Kang, S. W., & Lee, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109775 · Cited by 113
Raemdonck, K. V., Umar, S., Palasiewicz, K., Volkov, S., Volin, M. V., Arami, S., Chang, H. J., Zanotti, B., Sweiss, N., & Shahrara, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03235-w · Cited by 111
Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease
Zhang, Y., Liu, J., Wang, C., Liu, J., & Lu, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672346 · Cited by 109
Tu, J., Huang, W., Zhang, W., Mei, J., & Zhu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655477 · Cited by 105
Park, S. Y., Lee, S. W., Lee, S. Y., Hong, K., Bae, S., Kim, K., & Kim, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01135 · Cited by 104
Lacerte, P., Brunet, A., Egarnes, B., Duchêne, B. L., Brown, J. P., & Gosselin, J. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0901-1 · Cited by 87
Cutolo, M., Soldano, S., Montagna, P., Sulli, A., SERIOLO, B., Villaggio, B., Triolo, P., Clerico, P., Felli, L., & Brizzolara, R. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2865 · Cited by 86
Self-citationMalemud, C. J., & Miller, A. H. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.171 · Cited by 82
Rodríguez‐Ubreva, J., de la Calle‐Fabregat, C., Li, T., Ciudad, L., Ballestar, M. L., Català‐Moll, F., Morante-Palacios, O., García-Gómez, A., Celis, R., Humby, F., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215355 · Cited by 73
Görtz, B., Hayer, S., Tuerk, B., Zwerina, J., Smolen, J. S., & Schett, G. A. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1797 · Cited by 70
Cai, W., Cheng, J., Zong, S.-Y., Yu, Y., Wang, Y., Song, Y., He, R., Yuan, S., Chen, T., Hu, M., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.007 · Cited by 64
Rückert, R., Brandt, K., Ernst, M., Marienfeld, K., Csernok, E., Metzler, C., Budagian, V., Bulanova, E., Paus, R., & Bulfone‐Paus, S. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02878.x · Cited by 56
Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
Herenius, M. M. J., Thurlings, R. M., Wijbrandts, C. A., Bennink, R. J., Dohmen, S. E., Voermans, C., Wouters, D., Izmailova, E. S., Gerlag, D. M., van Eck‐Smit, B. L. F., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141549 · Cited by 53
Cutolo, M., Soldano, S., Gotelli, E., Montagna, P., Campitiello, R., Paolino, S., Pizzorni, C., Sulli, A., Smith, V. M., & Tardito, S. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02691-9 · Cited by 52
Self-citationPillars Article: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J. Immunol. 2000. 164: 6166–6173
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701141 · Cited by 48
New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
Pagani, S., Bellan, M., Mauro, D., Castello, L. M., Avanzi, G. C., Lewis, M., Sainaghi, P. P., Pitzalis, C., & Nerviani, A. (2020) · Disease Markers · doi:10.1155/2020/1614627 · Cited by 43
Narisawa, M., Kubo, S., Okada, Y., Yamagata, K., Nakayamada, S., Sakata, K., Yamaoka, K., & Tanaka, Y. (2020) · Bone · doi:10.1016/j.bone.2020.115616 · Cited by 43
Paolino, S., Pacini, G., Patanè, M., Alessandri, E., Cattelan, F., Goegan, F., Pizzorni, C., Gotelli, E., & Cutolo, M. (2019) · Reumatologia/Rheumatology · doi:10.5114/reum.2019.86425 · Cited by 42
Self-citationCao, Y., Liu, J., Huang, C., Tao, Y., Wang, Y., Chen, X., & Huang, D. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.10.005 · Cited by 39
Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer
Degboé, Y., Poupot, R., & Poupot, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031496 · Cited by 35
Matsuura, Y., Kikuta, J., Kishi, Y., Hasegawa, T., Okuzaki, D., Hirano, T., Minoshima, M., Kikuchi, K., Kumanogoh, A., & Ishii, M. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212880 · Cited by 33
Smiljanovic, B., Grützkau, A., Sörensen, T., Grün, J. R., Vogl, T., Bonin, M., Schendel, P., Stuhlmüller, B., Claußnitzer, A., Hermann, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64431-4 · Cited by 31
Amoruso, A., Sola, D., Rossi, L. C., Obeng, J. A., Fresu, L. G., Sainaghi, P. P., Pirisi, M., & Brunelleschi, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.034 · Cited by 27
Jian, L., Li, C., Wang, X., Sun, L., Ma, Z., & Zhao, J. (2021) · Autoimmunity · doi:10.1080/08916934.2021.2007374 · Cited by 21
Synovial macrophage populations linked to RA remission
McHugh, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0481-6 · Cited by 10
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Research works printed but not linked: 16
- Siddle, 2014, Anatomical Location of Erosions at the Metatarsophalangeal Joints in Patients With Rheumatoid Arthritis, Rheumatology, 53, 10.1093/rheumatology/ket478 · doi:10.1093/rheumatology/ket478
- Turesson, 2013, Extra-Articular Rheumatoid Arthritis, Curr, Opin Rheumatol, 25, 10.1097/BOR.0b013e32835f693f · doi:10.1097/bor.0b013e32835f693f
- Alex, 2020, Exposure to Ambient Air Pollution and Autoantibody Status in Rheumatoid Arthritis, Clin Rheumatol, 39, 10.1007/s10067-019-04813-w · doi:10.1007/s10067-019-04813-w
- Weldon, 2015, Surface APRIL Is Elevated on Myeloid Cells and Is Associated With Disease Activity in Patients With Rheumatoid Arthritis, J Rheumatol, 42, 10.3899/jrheum.140630 · doi:10.3899/jrheum.140630
- Crilly, 2012, PAR(2) Expression in Peripheral Blood Monocytes of Patients With Rheumatoid Arthritis, Ann Rheum Dis, 71, 10.1136/annrheumdis-2011-200703 · doi:10.1136/annrheumdis-2011-200703
- Ellingsen, 2014, Upregulated Baseline Plasma CCL19 and CCR7 Cell-Surface Expression on Monocytes in Early Rheumatoid Arthritis Normalized During Treatment and CCL19 Correlated With Radiographic Progression, Scand J Rheumatol, 43, 91, 10.3109/03009742.2013.803149 · doi:10.3109/03009742.2013.803149
- Cutolo, 2013, Intracellular NF-kB-Decrease and IKBalpha Increase in Human Macrophages Following CTLA4-Ig Treatment, Clin Exp Rheumatol, 31
- Brizzolara, 2013, Rapid Interaction Between CTLA4-Ig (Abatacept) and Synovial Macrophages From Patients With Rheumatoid Arthritis, J Rheumatol, 40, 10.3899/jrheum.120866 · doi:10.3899/jrheum.120866
- Schett, 2000, Activation, Differential Localization, and Regulation of the Stress-Activated Protein Kinases, Extracellular Signal-Regulated Kinase, C-JUN N-Terminal Kinase, and P38 Mitogen-Activated Protein Kinase, in Synovial Tissue and Cells in Rheumatoid Arthritis, Arthritis Rheumatol, 43, 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K · doi:10.1002/1529-0131(200011)43:11<2501::aid-anr18>3.0.co;2-k
- Salisbury, 1987, Macrophage-Like Cells of the Pannus Area in Rheumatoid Arthritic Joints, Scand J Rheumatol, 16, 10.3109/03009748709102927 · doi:10.3109/03009748709102927
- Combe, 2015, Comparison of the Long-Term Outcome for Patients With Rheumatoid Arthritis With Persistent Moderate Disease Activity or Disease Remission During the First Year After Diagnosis: Data From the ESPOIR Cohort, Ann Rheum Dis, 74, 10.1136/annrheumdis-2013-204178 · doi:10.1136/annrheumdis-2013-204178
- Obeng, 2016, Modulation of Human Monocyte/Macrophage Activity by Tocilizumab, Abatacept and Etanercept: An In Vitro Study, Eur J Pharmacol, 780, 10.1016/j.ejphar.2016.03.028 · doi:10.1016/j.ejphar.2016.03.028
- Schatz, 2016, Resolution of Pericardial Constriction With Anakinra in a Patient With Effusive-Constrictive Pericarditis Secondary to Rheumatoid Arthritis, Int J Cardiol, 223, 10.1016/j.ijcard.2016.08.131 · doi:10.1016/j.ijcard.2016.08.131
- Weisman, 2006, Reduction of Inflammatory Biomarker Response by Abatacept in Treatment of Rheumatoid Arthritis, J Rheumatol, 33
- Cutolo, 2016, Effects of Combined Treatments With CTLA4-IG (Abatacept), Dexamethasone and Methotrexate on Cultured Human Macrophages, Clin Exp Rheumatol, 34
- Cutolo, 2018, Testing the Anti-Osteoclastic Function of Biological DMARDs, Nat Rev Rheumatol, 14, 10.1038/s41584-018-0046-0 · doi:10.1038/s41584-018-0046-0
Cited by
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Yan, L., Wang, J., Cai, X., Liou, Y., Shen, H., Hao, J., Huang, C., Luo, G., & He, W. (2024) · MedComm · doi:10.1002/mco2.658 · Cited by 343
Wang, L., & He, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967193 · Cited by 324
Metadata
- Authors
- Cutolo, M., Campitiello, R., Gotelli, E., & Soldano, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-05-19
- Volume
- 13
- Pages
- 867260-867260
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4280542784
- Cited by
- 631
- References
- 95
- FWCI
- 75.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.